Israel Englander’s Cardio Diagnostics CDIO Stock Holding History

Israel Englander’s Portfolio CDIO Stock Details CDIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-8,565	Closed	-$236K	–	5909
2024 Q4	$236K	Buy	+8,565	New	+$119K	﹤0.01%	5209

Other funds holding CDIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Israel Englander's CDIO Position: Q1 2025 in Review

Israel Englander sold out of Cardio Diagnostics (CDIO) in Q1 2025, closing a stake of 8,565 shares — an estimated $236K sold.

Israel Englander first reported a position in CDIO in Q4 2024 and held it in 1 quarter. The position peaked at $236K in Q4 2024. 23 funds tracked by Wall St. Rank hold CDIO as of Q1 2025.

Israel Englander reported no remaining Cardio Diagnostics position as of Q1 2025 after selling out during the quarter.
Israel Englander sold 8,565 Cardio Diagnostics shares in Q1 2025, an estimated $236K.
Israel Englander first reported a position in Cardio Diagnostics in Q4 2024 and held it in 1 quarter.
Israel Englander's Cardio Diagnostics position peaked at $236K in Q4 2024.
23 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q1 2025.

Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.